WHO IS DR NVER M FRENK*

---

Independent researcher, integrative medicine. Author and developer of a rehabilitation and treatment course (protocol) for patients with advanced cancer.

Dr. Nver M. Frenk, a recent U.S. citizen, is a licensed oncological surgeon (foreign degree)* and rehabilitation specialist, with over 28 years of experience in oncological research and clinical practice as a licensed oncological surgeon in Russia and as an invited physician in the countries of Eastern and Western Europe, the Caucasus, and  Asia. 

• Altai State Medical University – Doctor of Medicine (M.D.), 1996 (course of study 1990–1996)
• Volgograd State Medical University, Faculty of Advanced Medical Training – Clinical Residency and PhD studies (Aspirantura), Department of Surgery, 1996–1999
• Volgograd Medical Academy – Advanced Continuing Medical Education (CME) Training on the fundamental usage of diagnostic and therapeutic minimally invasive interventions in surgery and traumatology, 1998 
• Volgograd Medical Academy – Advanced Continuing Medical Education (CME) Training on emergency surgery of the abdominal cavity, 1999 
• Altai State Medical University – Advanced Professional Development Course in Oncology, 2006

•  Registered copyright (2008) – treatment methodology: Complex of Therapeutic Measures – Rehabilitation of Severe Oncology Patients.
• U.S. patent application (2012) – Method of Rehabilitation of the Most Severe Cancer Patients (initial application, withdrawn voluntarily).
• Eurasian patent application (2012) – Method for the Rehabilitation of Patients with Oncological Diseases in Particularly Severe Stages (initial application, withdrawn voluntarily).
• Copyright submitted for registration with the U.S. Copyright Office (2026) – written description of theComprehensive Rehabilitation and Treatment Program (Protocol) for Patients with Advanced Cancer: Certain Aspects.

Before moving to the U.S., he specialized in the most complex cases and served as an invited physician providing second opinions at hospitals across Russia, Eastern and Western Europe, and other countries, as well as treating high-profile patients. 

Over his clinical career he developed treatment protocols intended to rehabilitate patients at terminal stages of cancer, including those for whom conventional treatments offered no further options. He is an author and developer of the innovative treatment method for patients with advanced terminal-stage cancer. 

Today he applies that clinical foundation to research and expert services. He is currently a New York-based researcher working on cellular contributions to carcinogenesis and recovery in severe disease alongside Dr. G. Rein, Ph.D.

All changes in DNA are the result of long-term effects of aggressive factors at the cellular-molecular level. Every second, DNA is subjected to external influence and damage, and this is a physiological process. The self-repair of DNA likewise occurs every second, and the slightest changes — in either the structural or the energy resource within cells — are enough to lead to reversible (modification) or irreversible (mutation) changes in DNA. Thus, the change of conditions for the DNA level is, in fact, a protective-adaptive reaction that ensures the survival of a group of cells under new pathological realities. And, in essence, carcinogenesis at all of its levels is a "physiological" process for this group of cells.

The struggle against a natural process is, unfortunately, not successful, because it does not take into account the interests of the pathological process in question. Combating cancer is possible only with a comprehensive approach, and only by eliminating the complex of provoking factors and creating normal conditions at all levels of metabolism. Carcinogenesis is the result of profound metabolic disturbances, and is their final stage. Accordingly, this approach is fundamentally etiopathogenetic, targeting underlying disease mechanisms rather than focusing primarily on symptom management.

In documented terminal cases where conventional oncology protocols had been exhausted or were contraindicated, patients treated with Dr. Frenk's method showed significant clinical improvement—some resuming conventional treatment such as chemotherapy and immunotherapy, others returning to daily life with survival extended by years. In some instances, complete regression was observed.

His approach is comprehensive and integrated. It acts not only on the symptoms but on the root causes, the etiology, of diseases, blocking the pathological mechanisms of the disease's progression — the pathogenesis. 

The approach is based on creating conditions at the cellular level that reduce the formation of free radicals, which he considers central to the pathogenesis of the disease. Rather than providing an antioxidant effect from the outside, the goal is to stimulate the cell's own antioxidant capacity, so that the body achieves this state through its own protective, self-regulating mechanisms. The key task is preserving the integrity of the lipid membranes of cells and of intracellular organelles, which he considers fundamental to the antitumor and anti-inflammatory effect.

Since the body represents a single multifunctional complex with an exclusively cellular structure, enhancing intracellular energy-producing processes — adenosine triphosphate (ATP) formation — raises the overall energy charge of all the body's cells; and, by the principle of energy redistribution, immunocompetent cells (including T-lymphocytes) acquire a powerful energy charge, which he regards as the guarantor of a strong antitumor immune response by the body.

Increasing the synthesis of ATP ensures the energy status of both the cells and the entire organism. A decrease in ATP synthesis in the mitochondria by as little as 10% (according to the cellular energy charge formula) leads to a twofold rise in the level of adenosine diphosphate (ADP), which significantly lowers the cells' energy resources to a critical level. Cells with a near-zero energy charge are extremely dangerous, as they lose the capacity for natural apoptosis along with their most essential physiological functions.

When mitochondrial respiration — through which adenosine triphosphate (ATP), the universal source of energy for all cells, is synthesized — is disrupted, the resulting profound metabolic disorder also suppresses the formation of intracellular "metabolic water" (on the order of 400–500 ml per day), which serves as a medium for numerous biochemical reactions in hard-to-reach intermolecular chains (bonds) inside the cells throughout the body. By creating temporary protective factors (enhancing antioxidant properties at the cellular level) and promoting the normalization of the functioning of physiological barriers, the approach seeks to reduce the burden of aggressive factors on the body.

His method consists in creating more favorable, low-stress conditions for the weakened organism, which supports recovery of the immune system and ensures a reliable and "sober" response to atypical and pathological cells.

Treatment Foundations:

1. Boosting immunity.
2. External administration of alpha and gamma interferons, as well as administration of inducers of interferon-forming processes.
3. Elimination of intestinal malabsorption syndrome, which creates an alimentary (nutritional) deficiency.
4. Elimination of intestinal dysbacteriosis and restoration of the physiological pH of the gastrointestinal tract.
5. Creation of mechanisms for eliminating chronic hypoxia at the cellular level. 
6. Goal: Creating protective, temporary, blocking artificial barriers in the gastrointestinal tract to restore the intestinal mucosa, which plays an important role in the process of intoxication of an endogenous nature.
7. Goal: Increasing antioxidant properties at the cellular level and reducing the mechanisms that provoke oxidative stress on cell membranes.

CAR-T cells are the patient's own immune cells (T-lymphocytes) which, when reprogrammed in the laboratory, begin to recognize and destroy cancer cells in the body. Dr. Frenk has experience initiating this same process within the body by engaging certain intra- and extracellular biochemical reactions at the level of the cells and intracellular organelles. In the laboratory, the already-programmed T-cells can work up to a certain point, since the mutation and atypia of tumor cells are constantly progressing in a worse, unpredictable direction; and only by using the capabilities of our own organism are good long-term results possible — provided special, key rehabilitation courses of a comprehensive nature are applied. He developed those courses, and they have proved consistently effective.

Prescribing oral probiotics does not solve the problem; on the contrary, in weakened cancer patients—who already have atrophy of the mucous membrane along the entire length of the gastrointestinal tract—an increased bacterial load develops. As they pass through the upper sections of the gastrointestinal tract, probiotics lose both their quantitative and qualitative properties and also alter the acid-base balance, which inactivates digestive enzymes and impairs the absorption of nutrients, vitamins, and minerals. Moreover, the immune system becomes even further weakened. In intestinal dysbiosis, opportunistic bacteria release toxins that, once absorbed into the bloodstream, cause intoxication of the liver and of the entire body. Dr. Frenk’s development in this field has produced notably positive outcomes when the full protocol is followed.

Email: frenkm@qresearchlab.com 

Phone number: + 1 929 787 5414

* This page is for informational and research purposes only. It describes Dr. Frenk's research interests and prior clinical work conducted outside the United States. Dr. Frenk is not licensed to practice medicine in the United States or New York and does not treat patients here. Nothing on this page is medical advice or an offer to diagnose or treat any condition, and it is not a substitute for care from your physician. Statements here have not been evaluated by the FDA. Always consult your physician or a local healthcare provider about any medical condition